Bevacizumab-induced arrhythmia in a patient with lung adenocarcinoma: A case report

RATIONALE: Cardiotoxicity is an important side effect of vascular endothelial growth factor inhibitors therapy in the treatment of cancer. Massive studies have shown bevacizumab-related hypertension, venous, and arterial thrombosis. PATIENT CONCERNS: A 56-year-old female patient was treated with bev...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jing, Zhang, Furong, Lu, Yuanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476766/
https://www.ncbi.nlm.nih.gov/pubmed/37657003
http://dx.doi.org/10.1097/MD.0000000000034799

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10476766/
https://www.ncbi.nlm.nih.gov/pubmed/37657003
http://dx.doi.org/10.1097/MD.0000000000034799

Ejemplares similares